X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS BIOCON LTD DR. DATSONS LABS/
BIOCON LTD
 
P/E (TTM) x -10.9 94.8 - View Chart
P/BV x 0.2 7.7 2.1% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 DR. DATSONS LABS   BIOCON LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
BIOCON LTD
Mar-17
DR. DATSONS LABS/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1261,162 10.8%   
Low Rs31483 6.4%   
Sales per share (Unadj.) Rs133.0194.6 68.4%  
Earnings per share (Unadj.) Rs0.234.4 0.4%  
Cash flow per share (Unadj.) Rs6.648.3 13.7%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %00.1 0.0%  
Book value per share (Unadj.) Rs128.8241.9 53.2%  
Shares outstanding (eoy) m31.66200.00 15.8%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.2 13.9%   
Avg P/E ratio x516.123.9 2,159.7%  
P/CF ratio (eoy) x11.817.0 69.5%  
Price / Book Value ratio x0.63.4 17.9%  
Dividend payout %02.9 0.0%   
Avg Mkt Cap Rs m2,477164,440 1.5%   
No. of employees `000NA9.2 0.0%   
Total wages/salary Rs m567,470 0.7%   
Avg. sales/employee Rs ThNM4,213.9-  
Avg. wages/employee Rs ThNM809.0-  
Avg. net profit/employee Rs ThNM745.2-  
INCOME DATA
Net Sales Rs m4,21138,911 10.8%  
Other income Rs m791,571 5.0%   
Total revenues Rs m4,28940,482 10.6%   
Gross profit Rs m5699,795 5.8%  
Depreciation Rs m2042,772 7.4%   
Interest Rs m430260 165.5%   
Profit before tax Rs m138,334 0.2%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m61,616 0.4%   
Profit after tax Rs m56,881 0.1%  
Gross profit margin %13.525.2 53.6%  
Effective tax rate %48.019.4 247.7%   
Net profit margin %0.117.7 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85240,477 16.9%   
Current liabilities Rs m6,71116,783 40.0%   
Net working cap to sales %3.360.9 5.5%  
Current ratio x1.02.4 42.3%  
Inventory Days Days16160 269.9%  
Debtors Days Days31883 384.4%  
Net fixed assets Rs m3,67345,073 8.1%   
Share capital Rs m3171,000 31.7%   
"Free" reserves Rs m3,76147,377 7.9%   
Net worth Rs m4,07848,377 8.4%   
Long term debt Rs m1,67121,082 7.9%   
Total assets Rs m12,63393,942 13.4%  
Interest coverage x1.033.1 3.1%   
Debt to equity ratio x0.40.4 94.0%  
Sales to assets ratio x0.30.4 80.5%   
Return on assets %3.47.6 45.3%  
Return on equity %0.114.2 0.8%  
Return on capital %7.712.6 60.9%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96412,988 7.4%   
Fx outflow Rs m6077,899 7.7%   
Net fx Rs m3575,089 7.0%   
CASH FLOW
From Operations Rs m1,3456,400 21.0%  
From Investments Rs m-2,256-4,985 45.2%  
From Financial Activity Rs m-1,200-1,775 67.6%  
Net Cashflow Rs m-2,111-473 446.2%  

Share Holding

Indian Promoters % 4.5 40.4 11.2%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 0.0 8.4 -  
FIIs % 1.4 10.7 12.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 19.9 472.9%  
Shareholders   20,807 109,995 18.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  DISHMAN PHARMA  J.B.CHEMICALS  

Compare DR. DATSONS LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Cuts Losses; TCS Up 3%(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day but clawed back some gains in the final hours of the trading window.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - FRESENIUS KABI ONCO. COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS